The global viral sensitizers market is on an accelerated growth trajectory, driven by growing demand for advanced antiviral therapies, increasing investments in biotechnology research, and rising incidences of viral infections. Valued at USD 2,033.24 million in 2024, the market is poised to expand to USD 2,326.63 million in 2025 and ultimately reach a...